UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1302-1311

2018

Volltextzugriff (PDF)

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

Journal of thoracic oncology, 2011-09, Vol.6 (9), p.1496-1504

2011

Volltextzugriff (PDF)

Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non-Small Cell Lung Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4569-4577

2017

Volltextzugriff (PDF)

IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4), p.866-876

2016

Volltextzugriff (PDF)

Pulmonary loose tumor tissue fragments and spread through air spaces (STAS): Invasive pattern or artifact? A critical review

Lung cancer (Amsterdam, Netherlands), 2018-09, Vol.123, p.107-111

2018

Volltextzugriff (PDF)

Immunocytochemistry for predictive biomarker testing in lung cancer cytology

Cancer cytopathology, 2019-05, Vol.127 (5), p.325-339

2019

Volltextzugriff (PDF)

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Journal of thoracic oncology, 2019-03, Vol.14 (3), p.377-407

2019

Volltextzugriff (PDF)

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization

Modern pathology, 2013-12, Vol.26 (12), p.1545-1553

2013

Volltextzugriff (PDF)

Establishing mesothelioma patient-derived organoid models from malignant pleural effusions

Lung cancer (Amsterdam, Netherlands), 2024-05, Vol.191, p.107542, Article 107542

2024

Volltextzugriff (PDF)

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer

PloS one, 2013-07, Vol.8 (7), p.e67876-e67876

2013

Volltextzugriff (PDF)

Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer

Journal of thoracic oncology, 2015-04, Vol.10 (4), p.611-618

2015

Volltextzugriff (PDF)

Is Mesothelioma in China Rare or Misdiagnosed?

Journal of thoracic oncology, 2017-04, Vol.12 (4), p.607-609

2017

Volltextzugriff (PDF)

Genomic characterisation of small cell lung cancer patient-derived xenografts generated from endobronchial ultrasound-guided transbronchial needle aspiration specimens

PloS one, 2014-09, Vol.9 (9), p.e106862-e106862

2014

Volltextzugriff (PDF)

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

Journal of thoracic oncology, 2013-04, Vol.8 (4), p.461-468

2013

Volltextzugriff (PDF)

Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium

Oncogene, 2022-01, Vol.41 (1), p.138-145

2022

Volltextzugriff (PDF)

The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature

Pathology, 2024-08, Vol.56 (5), p.662-670

2024

Volltextzugriff (PDF)

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

Journal of thoracic oncology, 2017-02, Vol.12 (2), p.334-346

2017

Volltextzugriff (PDF)

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer

Thorax, 2013-12, Vol.68 (12), p.1095-1104

2013

Volltextzugriff (PDF)

RE: Spread Through Air Spaces (STAS) is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung

Journal of thoracic oncology, 2020-07, Vol.15 (7), p.e116-e117

2020

Volltextzugriff (PDF)

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2018-03, Vol.142 (3), p.408-419

2018

Volltextzugriff (PDF)

Sex-Dependent Staging in Non–Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System

Clinical lung cancer, 2018-11, Vol.19 (6), p.e933-e944

2018

Volltextzugriff (PDF)

Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma

Molecular cancer therapeutics, 2017-08, Vol.16 (8), p.1610-1622

2017

Volltextzugriff (PDF)

Nodular pulmonary light chain deposition disease

Pathology, 2016-08, Vol.48 (5), p.515-518

2016

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(110)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non-Small Cell Lung Cancer

IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis

Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer

Pulmonary loose tumor tissue fragments and spread through air spaces (STAS): Invasive pattern or artifact? A critical review

Immunocytochemistry for predictive biomarker testing in lung cancer cytology

Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization

Establishing mesothelioma patient-derived organoid models from malignant pleural effusions

The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer

Comparison of Methods in the Detection of ALK and ROS1 Rearrangements in Lung Cancer

Is Mesothelioma in China Rare or Misdiagnosed?

Genomic characterisation of small cell lung cancer patient-derived xenografts generated from endobronchial ultrasound-guided transbronchial needle aspiration specimens

Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients

Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium

Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung

The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature

The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer

RE: Spread Through Air Spaces (STAS) is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society

Sex-Dependent Staging in Non–Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System

Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma

Nodular pulmonary light chain deposition disease

Suchergebnisse filtern